Welcome to Erasmus MC

November 13, 2025

World’s First Database for Advanced Cutaneous Squamous Cell Carcinoma

Researchers at the Erasmus MC Cancer Institute have developed a nationwide database containing a wealth of information on cutaneous squamous cell carcinoma (CSCC). This resource will soon enable doctors to provide more personalized treatments for patients with this type of skin cancer.

Read more

November 7, 2025

New mechanism in BRCA2 tumors discovered: why chemotherapy sometimes fails

Why do some BRCA2 tumors eventually stop responding to chemotherapy? Researchers at Erasmus MC discovered how these tumors are still able to repair their DNA damage and how they evade the effects of chemotherapy.

Read more

November 4, 2025

Nearly €20 Million to Drive Innovation in Imaging Technology

A national consortium led by Erasmus MC has been awarded €19.6 million through the NWO Large-Scale Research Infrastructures program. The consortium, known as AMICE (Advanced Multimodal Imaging Centers), will invest over the next decade in advancing and refining imaging technologies that are essential for cutting-edge biomedical research.

Read more

October 30, 2025

Screening reduces prostate cancer mortality, even after more than twenty years

A prostate cancer screening program can reduce prostate cancer mortality, even in the long term. That is the take-away from research conducted by Erasmus MC in a large European group of screened men. ‘The longer the follow-up, the more reliable the results.’

Read more

October 8, 2025

Biomarker may predict Parkinson’s disease progression

Researchers at Erasmus MC have discovered a biomarker in the blood that can predict the progression of Parkinson’s disease. ‘Knowing how severe the disease will be in three years allows doctors to plan treatment much more precisely. ’

Read more

July 28, 2025

New Erasmus MC Subsidiary Develops Personalized Immunotherapy

Erasmus MC has established a new company dedicated to developing a new form of immunotherapy. This new therapy — a personalized cancer vaccine — is intended for patients with pancreatic cancer.

Read more

July 7, 2025

Prof. Stefan Sleijfer reappointed as dean and chair of the Executive Board of Erasmus MC

New term of five years

Read more

December 5, 2024

Changed parking fees visitors Erasmus MC

The municipality of Rotterdam will increase parking fees in all car parks (including the Museumpark garage) as of 1 January 2025. To prevent visitors of surrounding facilities from using the parking garages on Wytemaweg and Westzeedijk, Erasmus MC will also raise rates as of 1 January.

Read more

October 25, 2024

Paul Boomkamp reappointed as director and CFO Erasmus MC

The Supervisory Board has reappointed Dr Paul Boomkamp as member and CFO of the Erasmus MC Executive Board. The reappointment takes effect from 1 November 2024 and is for a period of five years.

Read more